2 active not recruiting, 2 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow R21: new trials by email Literature Review of R21 trials Research Report on R21
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M R21, RH5.1, R78C - Malaria,Falciparum | Phase 2 | Active not recruiting | University of Oxford | 360 | 2025-12-15 | 2026-10-21 |
| A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine) R21, RH5.1, R78C - Malaria,Falciparum | Phase 1 | Active not recruiting | University of Oxford | 56 | 2025-09-15 | 2026-10-21 |
| Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults R21, Pfs230D1-CRM197, Pfs230D1-EPA - Prevention of Malaria Transmission and Clinical Malaria | Phase 1 | Completed | Serum Institute of India Pvt. Ltd. | 240 | 2024-08-30 | 2026-02-10 |
| A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1 R21, Matrix-M1 - Malaria | Phase 1 | Completed | University of Oxford | 31 | 2015-10-15 | 2019-11-12 |
Malaria, Falciparum (2) · Malaria (1)
University of Oxford (3) · Serum Institute of India Pvt. Ltd. (1)
Burkina Faso (2) · Mali (1) · United Kingdom (1)
Halidou Tinto (1)